Board and Committee

Ugo Amaldi

Ugo Amaldi is a member of the ADAM Board of Directors. He has been Research Director and a researcher at Istituto di Sanità (the Italian Health Institute) and, later, at CERN. He has published more than 400 papers about the physics of atoms nuclei and particles, of radiations and their production and detection, and theoretical physics. His most known paper on the unification of the fundamental forces has been quoted 1200 times.

From 1980 to 1993 he created and directed the DELPHI collaboration which, formed of about 500 physicists coming from 20 countries, built and operated at the CERN elecronpositron collider LEP, the large detector bearing the same name. Chair professor of Medical physics, he has taught this subject in Florence and Milan University.

Founder and President of the TERA Foundation since its creation in 1992, in the last 15 years he has concentrated on developing techniques of cancer therapy which make use of beams of charged hadrons. To date, more than one million Italian high school pupils have studied his physics text books. He is Doctor honoris causa of the University of Helsinki, Lyon, Valencia and Uppsala and is member of the Italian Academy of Sciences.

Luca Campaiola

Luca Campaiola is a member of BRAHMA AG Board of Directors. He worked previously as an investment manager for the private equity funds managed by myQube S.A. and for a Family Office.

During his career he has worked in Milan, Geneva, Berlin and Cupertino.
Luca has been responsible for Merger & Acquisition and Start up Development within ICT, Energy, and Business Processing sector.
During his experience in myQube, he also advised the Strategic Technology Planning Department of Telecom Italia for technology scouting on the Next Generation Network Infrastructures in US. 

He was appointed to the Board of A4Vision, Nanotron, Minerva Networks, FSB and SPF Energy Group. He started his career in Sweden, as a Financial Analyst in Red Message AB.
Luca Campaiola was born in 1976 and graduated in Business Administration at Bocconi University, Milan. He attended an MBA in Entrepreneurship at Stockholm School of Economics.

Alberto Colussi

Alberto Colussi is the Founder and President of ADAM. He has been the Chairman Emeritus of AGB Nielsen Media Research a global Group operating in 35 Countries providing TAM services (Television Audience Measurement) to Advertisers, Advertising Agencies and Television Stations.

In 1964 Alberto Colussi founded LCM in Italy, a market research company lately named AGB. Focusing exclusively on TAM, AGB gradually expanded on 28 international markets. In 2004 AGB and AC Nielsen agreed to merge their TAM activities (ex. USA & Canada) and AGB Nielsen Media Research was established. Alberto Colussi was born in Venice in 1938 and graduated in business administration at Ca’Foscari University in the same town.

Niccolo Colussi

Niccolò Colussi is a member of BRAHMA AG Board of Directors. Previously he served different roles within the AGB Group, which operated globally in TV Audience Measurement.

Niccolò was the Managing Director and co-Founder of the Software Division, a spin off from the AGB Corporate Support Center. Under his tenure the team has grown four-folds and has created the worldwide leading TV Ratings Analysis software, which today has over 20'000 users in 35 different Countries.

In 2010, following the acquisition of the AGB Group by Nielsen (listed in NY stock exchange NLSN:US), Niccolò was appointed CIO of the International Media Business overseeing a team of 150+ developers spread in multiple locations across the globe. He has accomplished the integration of different teams and has succeeded in harmonizing Technology and Infrastructure in over 30 Countries.
Niccolò was born in Rome in 1975, and has a degree in Business Administration from Università Bocconi, Milan. Niccolò is in a stable relationship and has two kids. In his private life he is interested in sports and cinema.

Lord David Evans

Lord David Evans has had an extensive career in printing & publishing and holds numerous chairmanships spanning across healthcare, media, business consultancy and charity. Following his own battle with cancer, David became president of the ‘Pioneers’ for Prostate Cancer UK; a strong supporter of Cancer Research UK and Deputy Chairman of Advanced Oncotherapy Plc. Developing the technology and treatment in fighting cancer is a cause close to his heart.

David was awarded a life peerage in 1998 for his services to charity and industry. He actively lobbies for ‘welfare to work’ and employment training programmes, served on the Select Committee for SME Exports and regularly sponsors healthcare focused charity functions to raise awareness. In 2012 he ran a successful fundraising event for the new University College Hospital Macmillan Cancer Centre.

In 2013 he became chairman of Newsdesk Media Ltd, a global partnership publishing company producing books for government and organisations, promoting foreign trade and investment. David is also currently Chairman of Senate Consulting Ltd, Evans Mitchell Books, Forum Print Management Ltd, TU Ink Ltd, and Kennedy Scott Ltd. He is Chairman of the Institute of Collaborative Working and a Fellow of the Chartered Institute of Marketing and the City and Guilds Institute.

Stephen MYERS

Stephen was born in Belfast, N. Ireland. He was responsible for the commissioning and energy upgrade of the Large Electron Positron Collider (LEP).

In 2008, he became Director of Accelerators and Technology until January 2014; during this time, he directed the repair of the LHC after the serious accident and steered the operation of the collider in 2010, 2011, and 2012. On July 4, 2012 the collider allowed the discovery of a “Higgs” boson.

He is currently Executive Chairman of ADAM SA.

He has received many awards; honorary doctorates from the University of Geneva and the Queen’s University of Belfast, the IOP Duddell Medal, and the 2010 International Particle Accelerator Achievement prize. In 2012 he was joint recipient of the European Physical Society “EPS Edison Volta prize”, and in June 2013 was awarded an OBE for services to science. In October 2013, he was jointly awarded the “Prince of Asturias” Prize (Spain).


Dr. Sinclair qualified in medicine from the Middlesex Hospital, London in 1967 and held a number of appointments at teaching hospitals in London. He became a Registrar in Psychiatry at the Maudsley Hospital and Institute of Psychiatry of London University before entering business in 1971.

Between 1971 and 1977 he held senior board positions with Allied Investments Limited, which had operating interests in nursing homes through Nestor Nursing Homes, nursing agencies through the British Nursing Association, deputising services for doctors, medical equipment distribution, the management of hospitals for governments in the Middle East and the operation of a health spa.

In 1979, he founded Sinclair Montrose Trust Limited as a private investment vehicle for him and his family. Dr Sinclair was chairman and founder of Lifetime Corporation Inc, a New York Stock Exchange listed healthcare company. He serves on the Board of Overseers (emeritus) of the Tufts University School of Medicine. He was also the chairman and founder of US based Atlantic Medical Management LLP, which managed the New York based healthcare venture fund, Atlantic Medical Capital LP. He is the Chairman of AIM traded company, Totally Plc.

Donatella Ungaro, PhD

Donatella has a master’s degree in physics from University of Bari, Italy, where she completed her thesis in collaboration with the University 'La Sapienza (Rome), on a research activity based on Physics and Music.

After completing her PhD in Finland at the Helsinki Institute of Physics, Donatella was hired by CERN in 2005, where she was awarded the CERN Fellowship position in the Technical Coordination Group of the CMS experiment, which is one of the two general all purpose particle physics detectors built on the Large Hadron Collider.

She then joined ADAM in 2008 as project leader, becoming promoted to Group Managing Director in 2010.


Enrico Vanni holds an engineering degree in chemistry from the Federal Polytechnic School of Lausanne, Switzerland, a Ph.D. in chemistry from the University of Lausanne, as well as a Master of Business Administration from INSEAD in Fontainebleau, France. He began his career as a research engineer at International Business Machines Corp. in California, United States, and joined McKinsey & Company in Zurich in 1980. He managed the Geneva office for McKinsey from 1988 to 2004, and consulted for companies in the pharmaceutical, consumer and finance sectors. He led McKinsey’s European pharmaceutical practice and served as member of the partner review committee of the firm prior to his retirement in 2007.

Since his retirement as director of McKinsey & Company in 2007, Enrico Vanni has been an independent consultant. He is currently a Vice Chairman of the Novartis Board of Directors. He is also a member of several boards of directors, in industries from healthcare to private banking for non-listed companies including Eclosion2, Denzler & Partners SA, Lombard Odier SA and Banque Privée BCP (Suisse) SA, all based in Switzerland.


Mr. Wolf has spent more than 35 years of his career in international commerce and industry, working closely with companies dealing with pharmaceuticals, minerals, metals, mining, oil and gas, hospitality, and real estate. He holds a Business degree from Middlesex University.